processo de avaliação do risco de mortalidade em pacientes que apresentam uma síndrome de resposta inflamatória sistêmica (sirs) ou sepse

a invenção se refere a um processo de avaliação do risco de mortalidade em pacientes que apresentam uma resposta inflamatória sistêmica (sirs) ou síndromes sépticas, compreendendo a medição da expressão de scd127 em uma amostra biológica. A kit for in vitro or ex vivo measurement of the expression of solubleCD127 in a biological sample, including: tools or reagents for measuring the expression of solubleCD127 in the biological sample; and a positive control sample, which is a sample calibrated to contain the quantity of sCD127 that corresponds to the mean quantity measured in a pool of samples from patients who have been subjected to an insult or to an infection generating a systemic inflammatory response who are known to have survived, and/or a negative control sample, which is a sample calibrated to contain the quantity of solubleCD127 that corresponds to the mean quantity measured in a pool of samples from patients who have been subjected to an insult or to an infection generating a systemic inflammatory response who are known not to have survived.